Objective: To investigate 24-h urinary thiamine as a potential biomarker for thiamine intake for use in validation studies to assess the validity of dietary intake data collected by self-reporting dietary methods. Subjects: Seven male and six female healthy participants living for 30 days in a metabolic suite under strictly controlled conditions consuming their usual diet as assessed beforehand from four consecutive 7-day food diaries kept at home. During the 30-day study, all 24-h urine specimens were collected, validated for their completeness and analysed for thiamine. Results: Thirty-day mean (7s.d.) calculated thiamine intake was 2.2270.55 mg/day. Thirty-day mean (7s.d.) urinary excretion of thiamine was 526.57193.0 mg/day (24.778.10% of intake). There was a highly significant correlation between individuals' 30-day means of thiamine intake and their mean excretion level (r ¼ 0.720; P ¼ 0.006), where 1 mg of thiamine intake predicted 268.2 mg of thiamine in urine. The correlations between intake and excretion remained significant when measurement from a single 24-h urine collection was used (r ¼ 0.56). Conclusion: Twenty-four-hour urinary thiamine can be used as a concentration biomarker for thiamine intake in dietary validation studies.
Introduction
Biomarker-based validation sub-studies are now integrated into large prospective cohort studies to quantify the measurement error of the intake estimates, to correct the attenuated relative risk for more precise interpretation of diet-disease association and to compare the relative accuracy of different dietary methods (Bingham et al., 1997; Brunner et al., 2001; McKeown et al., 2001; Sjoberg et al., 2003; Slimani et al., 2003; Subar et al., 2003) .
So far, few dietary biomarkers satisfy the criteria as suitable to validate estimates of self-reported nutrient intake and are in routine use in validation studies. Among them, 24-h urinary N as a marker for protein intake has been most well established and extensively used, followed by the doubly labelled water and 24-h urinary K for validation of energy and K intake estimates, respectively, all belonging to the group of recovery biomarkers which are based on a precise and quantitative knowledge of the physiological balance between intake and output (Bingham, 2002) . Concentration biomarkers are another group of biomarkers that are based on measurement of a nutrient or compound concentration at a given point . However, their use in validation purposes is limited because they cannot be translated into absolute estimates of intake but provide only a correlate to dietary intake level, such as plasma ascorbic acid, a-tocopherol and b-carotene, single 24-h urine N, fatty acids in adipose tissue, and so on (Kaaks, 1997) . A new category of biomarkers has recently been described, predictive biomarkers, involving urinary sugars that predict levels of sugar intake, the use of which in validation purposes needs to be further established (Tasevska et al., 2005) . However, a wider variety of dietary biomarkers is required to cover a larger range of foods and nutrients.
Thiamine (vitamin B 1 ) is a water-soluble vitamin present in nearly all natural foods. As it is so widespread, thiamine is a potential general marker of food consumption. Because of the importance of thiamine as an essential nutrient and availability of methodology for its determination in food, databases for intake values of thiamine are largely complete and reliable. For example in the United Kingdom, there are only about 4% of missing values for thiamine food composition database, most of them in the group of soups, sauces, herbs and spices, none of them particularly rich sources of thiamine (Food Standards Agency and Research, 2002) . Thiamine balance studies have demonstrated that the amounts recovered in the urine exhibit a close relationship with intake (Mason and Williams, 1942; Mickelsen et al., 1947; Sauberlich et al., 1979) . However, in these studies, the differences in thiamine intake were achieved by administration of thiamine supplements and not by food. Furthermore, the participants were exposed to set amounts of the vitamin rather than to their usual varied diet.
So far, no other study investigating urinary thiamine as a possible biomarker of dietary intake in participants under strictly controlled conditions has been conducted. In this paper, we have investigated the 24-h urinary output of thiamine as an objective marker of thiamine intake in participants consuming their habitual varying diet. They were housed in a metabolic suite in order that all the food consumed could be carefully weighed and all 24-h urines collected. Repeated observations allowed examination of reproducibility of urinary thiamine and its variance components from analysis of variance during the 30-day study period.
Methods
Experimental design Participants. A total of 13 healthy participants (7 males and 6 females) in the age range of 23-66 years (43.2715.9 years) from Cambridgeshire were recruited following local advertisements. They were of varied social backgrounds and occupations. Before the study, all participants were examined by a medical practitioner when their thiamine status was checked by measuring erythrocyte transketolase activity in fasting blood samples. Participants gave their informed written consent before joining the study. The study was approved by the Cambridge Local Research Ethics Committee (LREC no 02/323).
Dietary intervention. During the 30-day study, the participants lived in the volunteer suite of the MRC Dunn Human Nutrition Unit while consuming their usual diet. To assess their usual diet, the participants were asked to keep 7-day estimated food diaries for 4 weeks, while at home, before the 30-day study period. More detailed information, including food brand names, was obtained at weekly interviews with one of the investigators. Data from the food diaries were then used to replicate the usual daily diets of each subject during the study period. One-and-a-half times the amount of food anticipated to be eaten by the subject was prepared and then weighed to the nearest gram, labelled with the name and the day and then left in a separate refrigerator for each individual. During the day, participants helped themselves and returned the uneaten food in the containers to the refrigerator. The next day, the uneaten food was weighed out and the amount of food consumed was calculated.
Dietary intake was calculated from the UK food composition tables using DINER (Data Into Nutrients for Epidemiological Research) . Tea and coffee were consumed freely during the course of the study but participants were asked to keep their intake consistent. Five of the participants occasionally consumed alcohol; none reported alcohol-related problems. As alcohol is not permitted in the volunteer suite, these participants recorded the amount and type of alcohol consumed in their study diary. The calculated dietary intake for alcoholic drinks was added into the consumption data obtained in the study. Subjects complied with instructions not to consume supplements during the study, apart from two subjects who misunderstood: subject 7 consumed 0.5 mg for 5 days (days 4, 6, 8, 9 and 15) and subject 12 consumed 2 mg for 3 days (days 5, 8 and 17). These supplements have been added into the daily intake results.
Urine collections. Continuous urine collections were made throughout the whole study. Thirty 24-h urine samples, verified for their completeness with p-amino benzoic acid (PABA) (see below), were collected from every subject.
Specimen collection, handling and storage Upon entry, participants were instructed on the technique of 24-h urine collection. On the first day, they were asked to discard their first urine sample in the morning and from then on to collect all samples for 24 h including the first sample of the following day. The participants were given two 2-l plastic dark containers to collect the urine and a rucksack for carrying the bottles when they were out of the suite. Boric acid (3 g) was added to the containers as a urine preservative. In earlier studies, highly corrosive acids had been used as preservatives, that is glacial acetic acid (Mason and Williams, 1942; Mickelsen et al., 1947; Levy and Hewitt, 1971) , concentrated hydrochloric acid (Sauberlich et al., 1979) , concentrated sulphuric acid (Ziporin et al., 1965) , to maintain urine pH below 4 to ensure thiamine stability (ICNND, 1963) . However, thiamine is known to be stable in mildly acidic conditions, but becomes unstable and easily destructed at pH 8 or above, especially at high temperatures (Brody, 1999) . Therefore, boric acid, which can be safely handled and maintains urine pH around 6, was the preservative of choice. Because of the light sensitivity of thiamine, dark containers were used (ICNND, 1963) .
Daily urine collections were weighed and urine aliquots stored in amber bottles at À201C for further analysis within 4 h of completing the collection. The completeness of the 24-h urine was assessed by urinary recovery of three 80 mg tablets of PABA (PABAcheck, Laboratories for Applied Biology, London, UK) given to the participants to take with their meals (Bingham and Cummings, 1983) .
Urine collections with 485% recovery of the oral dose of PABA at the beginning of the collection period and 490% on succeeding days of the collection were considered as complete and stored for further analyses. When there was confusion over two succeeding 24-h collections (for example, low marker recovery on 1 day followed by a high marker recovery the next day), the average of the two collections was used in the statistical analysis. Participants recorded the time of taking PABA tablets or any missed urine collection in a diary, together with taking any medication.
Physical activity and body weight assessment Physical activity was recorded in the study diary on a daily basis as time (minutes) engaged in different type of exercise. A four-level score (inactive, moderately inactive, moderately active and active) was assigned by combining occupational physical activity together with time participating in higherintensity physical activities such as cycling, aerobics, exercising at a gym on a regular basis, swimming, jogging, and so on (Wareham et al., 2003) . Participants weighed themselves daily on an electric balance without shoes and in light clothing and recorded their body weight in the study diary.
Analytical methods PABA concentration in urine was measured by a colorimetric technique described elsewhere (Bingham and Cummings, 1983) .
Urinary thiamine was measured by an HPLC method with fluorescent detection for rapid determination of thiamine in foods, body fluids, urine and faeces, developed by Bötticher and Bötticher (1986) . The only modification of the method was that 1 min after addition of potassium-hexacyanoferrate-III solution, 0.1 ml sodium sulphite was added to halt the reaction of derivatization (Gauch et al., 1992) . For every run, standard solutions were made fresh in amber bottles by diluting the stock solution in the expected range of thiamine in the urine samples (10-300 ng/ml).
Calibration curves were linear over the concentration range required, 5-500 ng/ml. Urine samples spiked with standard gave 97.3% recovery. A urine quality control (QC) was included in every run. Inter-assay coefficient of variation (CV) and intra-assay CV for the QC were 6.5 and 3.5%, respectively. Poor repeatability of thiamine measurement was obtained at higher urine concentrations, so, before analysis, all aliquots were diluted to the equivalent of 15 l urine volume per 24-h collection.
Statistical methods SPSS version 11 for Windows was used for data analysis. P-values o0.05 were used to identify statistically significant result. Values are presented as means7s.d. and 95% confidence interval (CI). Individuals' body weights at the beginning and at the end of the study were compared by paired t-test. To compare body weight between men and women, an independent t-test was used. In this small group, there was no statistically significant difference in body weight between men and women (t ¼ 1.41; P ¼ 0.185), hence means are presented for the group as a whole.
Daily measurements of both dietary and urinary thiamine were skewed, hence they were log 10 transformed. Individuals' means of dietary thiamine were also skewed and they were normalized by log e transformation, whereas individuals' means of urinary thiamine were normally distributed. Spearman nonparametric correlation coefficients were used to examine colinearity between non-transformed dietary and urinary thiamine.
An analysis of variance random effect model was employed to quantify variance components in transformed thiamine intake and excretion data within and between participants. Reproducibility of the dietary intake and urinary excretion measurements was assessed by the within-subject variance and the intraclass correlation coefficient, calculated as the ratio of between-subject variance and the sum of within-and between-subject variance (s BS 2 /(s BS 2 þ s WS 2 )). The ratio of within-to between-subject variance (s WS 2 /s BS 2 ) was used to assess the ability to characterize individuals with regard to their intake/excretion measures, and to assess the attenuation effect of variability on the association between intake and excretion or to any other variable. To compare variability estimates to other studies, the CV (%CV; s.d./mean Â 100) was also used to estimate within-and between-subject variability in intake and excretion. A hierarchical regression model with the individuals' mean thiamine output in urine as an dependent and logtransformed mean thiamine intake as independent variable was fitted after adjusting for body weight and age. Note that because the dietary intake was known (but its relation to the biomarker was not), thiamine intake was treated as the independent variable. Physical activity, carbohydrate and alcohol intake did not contribute to the prediction ability of the model and made it unstable, thus they were not included.
The correlation between dietary and urinary thiamine if only a single 24-h urine collection were available was also investigated. Randomization of single urinary measurements was made 10 times for each subject separately, and then correlated with the 30-day means of dietary thiamine. To average individual Spearman correlation coefficients, they were first converted into z values using Fisher's z transformation, averaged, and then the means were back transformed to the correlation coefficient scale.
Results
A total of 390 daily urines were collected, 30 for each subject. Only four urine collections were excluded from the analysis. One was incomplete, two were excluded owing to spillage and one subject failed to take the daily PABA dose.
All 13 participants completed the study and remained healthy throughout. There was less than 1 kg change in body weight from the start to the end of the study in 10 subjects (body weight change, 0-0.8 kg). Three subjects gained or lost more than 1 kg (V7, þ 1.3 kg; V9, À1.0 kg; V12, þ 1.7 kg). The mean CV of the day-to-day body weight change for the group was 0.6470.25%. The mean weight did not change in the group as a whole, being 76.2715.1 kg at the start and 76.3715.0 kg at the end of the study (t ¼ À0.611; P ¼ 0.533). During the study, participants continued their normal occupational and recreational engagements. Three of the participants were physically inactive, four moderately inactive, five moderately active and one active. The most frequent physical activities were cycling, swimming, going to the gym, and playing badminton and squash.
The mean energy intake for this group consuming their usual diet for 30 days under controlled conditions was 11.671.7 MJ (Table 1) . Fat, protein and carbohydrate intake were 106.5728.8, 97.9715.3 and 372.8772 g/day, respectively. Mean calculated thiamine intake was 0.8070.15 mg/ 1000 kcal and in all of the participants was at least 60% above the RNI for British population (Department of Health, 1991) . There was no significant difference in thiamine intake between men and women (t ¼ 0.43; P ¼ 0.674); hence, means are presented for the group as a whole. Thiamine intake was derived from different food groups with the main contributors being unfortified and fortified cereals and cereal products (23%), vegetables (18.2%) and meats (12.5%) (see Table 2 ). The within-subject variance (s WS 2 ) in thiamine intake was higher than the between-subject variance (s BS 2 ), with the ratio between the two of 1.25 (Table 3) . Overall, 24.778.10% (95% CI ¼ 20-30%) of thiamine intake was excreted in the urine (range 11.9-41.5%) ( Table 1) . Although there was a high day-to-day variability of thiamine excretion in this group, the variability in excretion between participants was higher, generating a s WS 2 /s BS 2 ratio of 0.72 (Table 3) . The daily calculated thiamine intake was significantly correlated with the daily urinary thiamine in 10 of 13 participants, with individual correlation coefficients ranging from 0.382 to 0.705 (Table 1) . The correlation between daily urinary and dietary thiamine for each individual participant is shown in Figure 1 . A highly significant correlation was found between the individuals' 30-day means of thiamine intake and their mean excretion levels (r ¼ 0.72; P ¼ 0.006) (Figure 2 ). When thiamine intake from different food groups Table 1 Thirty-day mean and within-subject variation of dietary intakes of energy, macronutrients, alcohol and thiamine, and urinary thiamine and its correlation to intake in 13 participants on their habitual diet Urinary thiamine as a biomarker for thiamine intake assessment N Tasevska et al was correlated with urinary excretion, a significant correlation was found for thiamine from meat (r ¼ 0.58; P ¼ 0.039), fruits, nuts and seeds (r ¼ 0.57; 0.042) and vegetables and fruit juices (r ¼ 0.55; P ¼ 0.049), but no significant correlation with excretion was identified for any other food groups including cereals consisting of both fortified and unfortified products (Table 2 ). In the multiple regression model controlled for body weight and age, thiamine intake was the only significant predictor of thiamine excretion in the final model (adjusted R 2 ¼ 0.51; P ¼ 0.024) ( Table 4) . Other covariates (physical activity, alcohol and carbohydrate intake) did not have an effect; moreover, they made the model unstable, and thus were not included (for the exploratory regression model, see Table 4 ). As body weight and age did not explain a significant proportion of the variance in thiamine excretion, an unadjusted regression equation was derived by plotting the means of thiamine excretion against the non-transformed thiamine intake where 1 mg of thiamine intake predicted 268.2 mg of thiamine in urine (y ¼ 57.1 þ 211.1x). The mean correlation between the 30-day mean intake and thiamine measurement in a single 24-h urine collection was 0.56.
Discussion
In this 30-day study of 13 volunteers consuming their usual diet under strictly controlled conditions and collecting 24-h urinary specimens on a daily basis validated for their completeness, thiamine measured in the urine was significantly correlated with thiamine intake (r ¼ 0.72). The estimated mean intake of thiamine for the group was 2.2 mg/day or 0.81 mg/1000 kcal. The mean intake was very similar to the mean thiamine intake assessed in a UK nationally representative sample of adults aged 19-64 years, 2.2 mg/day in men and 1.94 mg/day in women (Henderson et al., 2003) , and arose from whole grain cereals, fruits and vegetables, as well as meat, biscuits, cakes and pastries, all characteristics of the UK diet. The fact that no weight was lost or gained on average over the study period of 1 month suggests that the intake achieved in this study was a reflection of usual dietary habits in these volunteers, despite the fact that all food consumed was accurately weighed.
The intake of thiamine was highly variable on a day-to-day basis (CV WS ¼ 27.4%) and the fact that the within-to between-subject variance ratio was greater than 1.0 (s WS 2 / s BS 2 ¼ 1.25) implies that a single or fewer measures of dietary intake would provide a poor estimate of the long-term thiamine dietary intake and may misclassify individuals for their intake. No other study to our knowledge has assessed day-to-day variation in thiamine intake in participants on their habitual diet under controlled conditions. Beaton et al. (1983) reported s WS 2 /s BS 2 ratios of 1.6 and 2.1 of thiamine intake assessed by six 24-h recalls, in men and women, respectively. Similar s WS 2 /s BS 2 estimates of 1.8 for men and 2.2 for women were reported by Nelson et al. (1989) from analysis of six studies. In the USDA 1994 Continuing Survey of Food Intakes, in a large representative sample of the US population, the within-subject variation in thiamine intake was also found to be greater than the between-subject Urinary thiamine as a biomarker for thiamine intake assessment N Tasevska et al variation and with similar ratios (males: CV WS ¼ 45%; CV BS ¼ 36%; females: CV WS ¼ 46%; CV BS ¼ 33%) (Willett, 1998) , but both were greater than the variation in our group. We observed less within-subject variation, probably because dietary intake was measured on 30 consecutive days rather than on more occasions separated by several months. Variability in thiamine excretion (CV WS ¼ 32.5%; CV BS ¼ 36.7%) was greater than the variability in the intake, but the s WS 2 /s BS 2 ratio was less than 1.0, which indicate better reproducibility of urinary thiamine measure. On average, 24.778.10% of thiamine intake was excreted in the urine but the wide range of recoveries between individuals (range 11.9-41.5%) and the large proportion (B50%) of unexplained variability in excretion indicates that the excretion level is individual specific and may be determined by other factors, rather than diet only. In the final regression model, although thiamine intake was the only known significant predictor of the urinary output, almost half of the proportion of the variance (B50%) was left unexplained, suggesting that other factors affect thiamine excretion to a certain extent. Alcohol, carbohydrate and physical activity were all expected to affect thiamine metabolism (Hoyumpa et al., 1977; Manore, 2000; Elmadfa et al., 2001) ; however, none of these potential confounders contributed to the predictive ability of the model, moreover they made it unstable, most possibly owing to the small sample size. Absorption-associated factors that could not be taken into account might have explained some of the variability seen here (Potischman, 2003) . For instance, absorption of thiamine may be impaired by different types of anti-thiamine factors present either naturally in some foods or used as food additives (Westwig et al., 1946; Hilker and Somogyi, 1982; Murata, 1982) . Furthermore, the existence of certain genetic determinants of thiamine tissue distribution and mutations in thiamine transporter-1 and thiamine transporter-2 have been proposed for explaining some of the variability in thiamine metabolism between individuals (Diaz et al., 1999; Singleton and Martin, 2001; Subramanian et al., 2006) ; however, this study was too small to examine interactions of this type, so no mutations were analysed.
The high between-subject variability in percentage urinary recovery of thiamine implies that urinary thiamine cannot act as a recovery biomarker and cannot provide a valid estimate of intake to assess under-reporting on individual level as is possible with urinary nitrogen (Bingham and Cummings, 1985) , urinary potassium (Tasevska et al., 2006) and doubly labelled water biomarker (Schoeller and van Santen, 1982) . Furthermore, only 50% of the variability in thiamine excretion was accounted for in the regression model, unlike the newly developed predictive biomarker for sugar intake where total sugar intake explained 72% in the variability of the biomarker (Tasevska et al., 2005) . However, the 30-day means of thiamine intake were highly correlated with thiamine excretion (r ¼ 0.720), showing that urinary thiamine alters in response to changes in diet with a correlation of 0.56, when only a single 24-h urine collection was available. This suggests that urinary thiamine can be used as a concentration biomarker. These correlations are better than those of other concentration biomarkers, whose correlations are usually in the range of about 0.4 or lower (van 't Veer et al., 1993; Kaaks et al., 1997) . This biomarker would provide a valuable addition to available biomarkers for use in validation studies, especially as dietary thiamine is widespread and present in a wide variety of foods.
A highly sensitive HPLC method using fluorescent detection, with no prior extraction of thiamine from the urine needed, is well established and may be easily introduced in any laboratory. Thiamine was shown to be stable in mildly acidic urine preserved with boric acid and kept in dark bottles at room temperature during collection. Thus, use of acid preservatives and special conditions for collecting the urine is not required so that collections can be made in Urinary thiamine as a biomarker for thiamine intake assessment N Tasevska et al epidemiological studies. Investigation of thiamine in partial 24-h urine collections as a concentration biomarker needs further investigation.
